Orbis Allan Gray Ltd holds a diversified book of 91 stocks worth $23.7B as of Q1 2026 (disclosed May 15, 2026, a ~45-day 13F lag). This quarter they opened Nvidia Corp and trimmed Qxo Inc. Their largest long position is Corpay Inc at 7% of the equity book.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1663865/holdings"
Use Arkolith to show Orbis Allan Gray Ltd's latest holdings, largest changes, and filing provenance.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices, no cost basis
Bars show each stock's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Corpay Inc COM SHS | $1.6B | 5.35M | 6.6% | ▲+7.2% Added · +357K sh | |
| 2 | Qxo Inc COM NEW | $1.4B | 73.95M | 6.1% | ▼−13% Reduced · −11.5M sh | |
| 3 | Nebius Group N.V. SHS CLASS A | $862.7M | 8.31M | 3.6% | ▲+149% Added · +5.0M sh | |
| 4 | Motorola Solutions Inc COM NEW | $811.5M | 1.87M | 3.4% | ▲+46% Added · +587K sh | |
| 5 | Praxis Precision Medicines I COM NEW | $796.6M | 2.47M | 3.4% | ▲+97% Added · +1.2M sh | |
| 6 | Eqt Corp COM | $770.9M | 12.11M | 3.3% | ▲+248% Added · +8.6M sh | |
| 7 | Alphabet Inc CAP STK CL A | $722.7M | 2.51M | 3.0% | ▼−5.7% Reduced · −151K sh | |
| 8 | Gxo Logistics Incorporated COMMON STOCK | $696.1M | 13.42M | 2.9% | —Held | |
| 9 | Xpo Inc COM | $663.2M | 3.41M | 2.8% | ▼−6.7% Reduced · −243K sh | |
| 10 | Bruker Corp COM | $648.0M | 17.94M | 2.7% | ▲+20% Added · +3.0M sh | |
| 11 | Westlake Corporation COM | $618.4M | 5.29M | 2.6% | ▲+21% Added · +907K sh | |
| 12 | Itau Unibanco Hldg S A SPON ADR REP PFD | $580.5M | 69.27M | 2.4% | ▼−15% Reduced · −12.4M sh | |
| 13 | Steris PLC SHS USD | $573.4M | 2.59M | 2.4% | ▲+15% Added · +343K sh | |
| 14 | Newmont Corp COM | $559.7M | 5.17M | 2.4% | ▼−18% Reduced · −1.2M sh | |
| 15 | Firstservice Corp New COM | $551.3M | 3.97M | 2.3% | ▲+100% Added · +2.0M sh | |
| 16 | Smurfit Westrock PLC SHS | $548.9M | 13.78M | 2.3% | ▼−1.3% Reduced · −182K sh | |
| 17 | Rxo Inc COMMON STOCK | $532.1M | 36.40M | 2.2% | ▲+5.0% Added · +1.7M sh | |
| 18 | British Amern Tob PLC SPONSORED ADR | $450.6M | 7.71M | 1.9% | ▼−17% Reduced · −1.6M sh | |
| 19 | Alnylam Pharmaceuticals Inc COM | $441.7M | 1.33M | 1.9% | ▼−18% Reduced · −283K sh | |
| 20 | Cinemark Hldgs Inc COM | $429.5M | 15.06M | 1.8% | —Held | |
| 21 | Cemex Sa Euro MTN Be 144A SPON ADR NEW | $424.9M | 37.14M | 1.8% | ▲+2.8% Added · +1.0M sh | |
| 22 | Interactive Brokers Group In COM CL A | $410.3M | 6.12M | 1.7% | ▼−34% Reduced · −3.2M sh | |
| 23 | Netease Com Inc SPONSORED ADS | $401.2M | 3.58M | 1.7% | ▲+5.8% Added · +195K sh | |
| 24 | Shell PLC SPON ADS | $382.6M | 4.11M | 1.6% | ▲+179% Added · +2.6M sh | |
| 25 | Kinder Morgan Inc Del COM | $379.2M | 11.31M | 1.6% | ▲+7.2% Added · +758K sh | |
| 26 | Nvidia Corporation COM | $364.5M | 2.09M | 1.5% | ▲New New position | |
| 27 | Disney Walt Co COM | $360.0M | 3.73M | 1.5% | ▲+4.8% Added · +172K sh | |
| 28 | Genmab A/s SPONSORED ADS | $346.8M | 12.93M | 1.5% | ▼−10% Reduced · −1.5M sh | |
| 29 | Booking Holdings Inc COM | $310.6M | 73.8K | 1.3% | ▲+140% Added · +43K sh | |
| 30 | Vale S A SPONSORED ADS | $308.2M | 19.37M | 1.3% | ▲+6.2% Added · +1.1M sh | |
| 31 | Insmed Inc COM PAR $.01 | $306.2M | 1.87M | 1.3% | ▼−55% Reduced · −2.3M sh | |
| 32 | Crispr Therapeutics AG NAMEN AKT | $290.5M | 6.11M | 1.2% | ▲+2.6% Added · +156K sh | |
| 33 | Diageo PLC SPON ADR NEW | $275.5M | 3.70M | 1.2% | ▲+113% Added · +2.0M sh | |
| 34 | Franco Nev Corp COM | $266.7M | 1.08M | 1.1% | ▼−23% Reduced · −330K sh | |
| 35 | Barrick MNG Corp COM SHS | $245.6M | 6.02M | 1.0% | ▼−9.9% Reduced · −662K sh | |
| 36 | Antero Resources Corp COM | $206.8M | 4.87M | 0.9% | ▲+555% Added · +4.1M sh | |
| 37 | Scholar Rock Hldg Corp COM | $205.5M | 4.18M | 0.9% | ▲+22% Added · +751K sh | |
| 38 | SPDR Gold TR GOLD SHS | $203.9M | 473.9K | 0.9% | ▼−9.5% Reduced · −50K sh | |
| 39 | BBB Foods Inc CL A COM | $199.7M | 5.65M | 0.8% | ▲+72% Added · +2.4M sh | |
| 40 | Imax Corp COM | $195.8M | 5.15M | 0.8% | —Held | |
| 41 | Renaissancere Hldgs Ltd COM | $192.7M | 648.5K | 0.8% | ▲+2.1% Added · +14K sh | |
| 42 | Robert Half Inc. COM | $191.7M | 7.55M | 0.8% | ▲New New position | |
| 43 | PDD Holdings Inc SPONSORED ADS | $178.2M | 1.74M | 0.8% | ▲+49% Added · +576K sh | |
| 44 | Aes Corp COM | $172.6M | 12.25M | 0.7% | ▼−43% Reduced · −9.1M sh | |
| 45 | Sea Ltd SPONSORD ADS | $152.7M | 1.84M | 0.6% | ▼−32% Reduced · −872K sh | |
| 46 | California Res Corp COM STOCK | $150.7M | 2.18M | 0.6% | ▲+13% Added · +251K sh | |
| 47 | Ryder Sys Inc COM | $145.7M | 711.7K | 0.6% | ▼−27% Reduced · −263K sh | |
| 48 | Brinker Intl Inc COM | $132.4M | 927.5K | 0.6% | ▲New New position | |
| 49 | Dyne Therapeutics Inc COM | $122.6M | 6.76M | 0.5% | ▲+41% Added · +2.0M sh | |
| 50 | Range Res Corp COM | $122.3M | 2.71M | 0.5% | ▲New New position |
As-of date vs the date the SEC received each filing
| Quarter | As of | Filed | Positions | Value | Form |
|---|---|---|---|---|---|
| Q1 2026 | Mar 31, 2026 | May 15, 2026 | 154 | $23.7B | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Feb 17, 2026 | 152 | $23.9B | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Nov 14, 2025 | 139 | $23.3B | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Aug 14, 2025 | 127 | $20.6B | 13F-HR |
| Q1 2025 | Mar 31, 2025 | May 15, 2025 | 112 | $17.5B | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Feb 14, 2025 | 136 | $18.6B | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 | 132 | $18.9B | 13F-HR |
| Q2 2024 | Jun 30, 2024 | Aug 14, 2024 | 125 | $16.1B | 13F-HR |
| Q1 2024 | Mar 31, 2024 | May 15, 2024 | 122 | $16.7B | 13F-HR |
| Q4 2023 | Dec 31, 2023 | Feb 14, 2024 | 123 | $15.9B | 13F-HR |
| Q3 2023 | Sep 30, 2023 | Nov 14, 2023 | 127 | $13.9B | 13F-HR |
| Q2 2023 | Jun 30, 2023 | Aug 14, 2023 | 127 | $14.0B | 13F-HR |
| Q1 2023 | Mar 31, 2023 | May 15, 2023 | 130 | $12.7B | 13F-HR |
| Q4 2022 | Dec 31, 2022 | Feb 14, 2023 | 133 | $12.6B | 13F-HR |
| Q3 2022 | Sep 30, 2022 | Nov 14, 2022 | 131 | $12.2B | 13F-HR |
| Q2 2022 | Jun 30, 2022 | Aug 15, 2022 | 131 | $12.4B | 13F-HR |
| Q1 2022 | Mar 31, 2022 | May 16, 2022 | 130 | $13.7B | 13F-HR |
| Q4 2021 | Dec 31, 2021 | Feb 14, 2022 | 117 | $13.5B | 13F-HR |
| Q3 2021 | Sep 30, 2021 | Nov 15, 2021 | 120 | $14.6B | 13F-HR |
| Q2 2021 | Jun 30, 2021 | Aug 16, 2021 | 118 | $15.8B | 13F-HR |
| Q1 2021 | Mar 31, 2021 | May 17, 2021 | 117 | $14.0B | 13F-HR |
| Q4 2020 | Dec 31, 2020 | Feb 16, 2021 | 114 | $13.8B | 13F-HR |
| Q3 2020 | Sep 30, 2020 | Nov 16, 2020 | 113 | $12.7B | 13F-HR |
| Q2 2020 | Jun 30, 2020 | Aug 14, 2020 | 114 | $13.3B | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly ~45 days after quarter-end. Public domain. The book and weighting are long equity only; disclosed put/call options are listed separately and excluded from those totals. Price-derived performance is withheld until the price-source policy and freshness gate are green.